Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05120648 · ClinicalTrials.gov registry record
Effects of Biofeedback on Somatic Symptoms
A clinical trial, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- 20
- Enrollment target
NCT05120648 is a clinical trial that has completed, run by University of California, Los Angeles. The registered enrollment target is 20 participants.
The verdict
NCT05120648 has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
Biofeedback is a therapeutic paradigm that teaches patients how to gain awareness and control over previously unrecognized sympathetic changes such as body temperature, blood pressure, and heart rate. We propose to use a six session biofeedback protocol that includes heart-rate variability (HRV) biofeedback, respiration/relaxation training, and body temperature control to treat UCLA patients with chronic medical conditions (e.g. pulmonary, neurology) and somatic symptoms (pain, psychosomatic non-epileptic seizures, panic attacks, long-COVID symptoms). The aim of the study is to determine whether patients who complete a six-session biofeedback protocol report a decrease in somatic symptoms, and improvements in self-rated mental health (depression, anxiety, quality of life) after the program and at three-months follow-up. The investigators will also study whether these improvements are also related to reduced healthcare utilization.
Interventions
- BEHAVIORAL Biofeedback
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2021-09-01 |
| Est. Completion | 2024-09-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05120648
The ClinicalTrials.gov registry entry for NCT05120648 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Biofeedback is the first listed.
NCT05120648 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05120648 about?
NCT05120648 is a clinical study titled "Effects of Biofeedback on Somatic Symptoms". Biofeedback is a therapeutic paradigm that teaches patients how to gain awareness and control over previously unrecognized sympathetic changes such as body temperature, blood pressure, and heart rate. We propose to use a six session biofeedback protocol that includes heart-rate variability (HRV) bio...
What is the current status of trial NCT05120648?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2021-09-01. Estimated completion is 2024-09-01.
What interventions are being tested in trial NCT05120648?
The interventions under investigation include: Biofeedback (BEHAVIORAL).
Who is sponsoring clinical trial NCT05120648?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.